Spontaneous but not experimental metastatic activities differentiate primary tumor-derived vs metastasis-derived mouse prostate cancer cell lines

被引:13
作者
Hall, SJ
Thompson, TC
机构
[1] BAYLOR COLL MED,SCOTT DEPT UROL,HOUSTON,TX 77030
[2] BAYLOR COLL MED,MATSUNAGA CONTE PROSTATE CANC RES CTR,HOUSTON,TX 77030
[3] BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030
[4] BAYLOR COLL MED,DEPT RADIOL,HOUSTON,TX 77030
[5] VET AFFAIRS MED CTR,UROL RES LAB,HOUSTON,TX 77030
关键词
metastasis; orthotopic mouse model; prostate cancer;
D O I
10.1023/A:1018499515883
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We previously developed an in vivo mouse prostate reconstitution (MPR) model of metastatic prostate cancer using p53 'knockout' mouse urogenital sinus tissue for retroviral transduction of ras and myc oncogenes (Thompson et al., Oncogene, 10, 869, 1995). We further demonstrated contrasting responses to transforming growth factor beta-1 (TGF-beta 1) in three matched pairs of early passage cell lines derived front primary prostate tumors and lung metastases generated by this model system (Sehgal et al., Cancer Res, 56, 3359, 1996). In this study we tested these cell lines for growth potential in subcutaneous and orthotopic (dorso-lateral prostate) locations and metastatic activities in both spontaneous and experimental assays, Subcutaneous and orthotopic tumors produced by cell lines derived from metastatic lesions tended to grow less rapidly but demonstrated greater spontaneous metastatic potential than the cell lines derived from primary tumors, In contrast all cell lines produced lung colonies in an experimental metastasis assay (tail vein inoculation) with the primary tumor-derived cell lines yielding higher activities in two of three matched pair analyses, The ability of all cell lines to produce lung metastases in the experimental assay, while only the metastasis-derived cell lines retain the ability to initiate and complete the entire metastatic pathway in the spontaneous assay, suggests that intravasation may be the rate-limiting step in metastasis in this model system.
引用
收藏
页码:630 / 638
页数:9
相关论文
共 39 条
[1]   PROGRESSION TO ANDROGEN INSENSITIVITY IN A NOVEL IN-VITRO MOUSE MODEL FOR PROSTATE-CANCER [J].
BALEY, PA ;
YOSHIDA, K ;
QIAN, W ;
SEHGAL, I ;
THOMPSON, TC .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 52 (05) :403-413
[2]  
BOTTAZZI B, 1986, INVAS METAST, V6, P44
[3]  
ECELES SA, 1980, BRIT J CANCER, V42, P252
[4]   PATHOLOGICAL AND CLINICAL FINDINGS TO PREDICT TUMOR EXTENT OF NONPALPABLE (STAGE-T1C) PROSTATE-CANCER [J].
EPSTEIN, JI ;
WALSH, PC ;
CARMICHAEL, M ;
BRENDLER, CB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (05) :368-374
[5]  
FIDLER IJ, 1990, CANCER RES, V50, P6130
[6]  
FU XY, 1992, INT J CANCER, V52, P987
[7]   METASTASIZING CAPACITY OF TUMOR-CELLS FROM SPONTANEOUS METASTASES OF TRANSPLANTED MURINE TUMORS [J].
GIAVAZZI, R ;
ALESSANDRI, G ;
SPREAFICO, F ;
GARATTINI, S ;
MANTOVANI, A .
BRITISH JOURNAL OF CANCER, 1980, 42 (03) :462-472
[8]  
ISAACS JT, 1997, UROL ONCOL, V2, P99
[9]  
JANIK P, 1975, CANCER RES, V35, P3698
[10]  
KRIPKE ML, 1978, CANCER RES, V38, P2962